US Tariffs Not A Bitter Pill For Indian Pharma Makers
New Delhi: The 100 per cent US tariffs on branded and patented pharmaceutical drugs is not a bitter pill for the Indian drug makers, according to analysts. That is because exports to the US — accounting for 20 per cent of the Indian pharmaceuticals market — primarily comprise generic, off-patent medicines which may not come…
